Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mitrionics was a Swedish technology company that specialized in high-performance computing (HPC) acceleration using Field Programmable Gate Arrays (FPGAs). The company developed the Mitrion Virtual Processor and the Mitrion-C parallel programming language, which allowed software developers to utilize FPGA hardware without needing traditional hardware design skills. Mitrionics gained significant traction in the life sciences sector by providing accelerated versions of bioinformatics tools, most notably NCBI BLAST, which achieved performance increases of up to 20 times over traditional processors. Headquartered in Lund, Sweden, the company partnered with major supercomputing firms like SGI, Cray, and Nallatech. Despite its early success and venture backing, the company ceased operations around 2018.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mitrionics.